Treatment of chronic hepatitis C in active drug users.
Davis
G L
GL
University of Florida College of Medicine, Gainesville 32610-0214, USA.
Rodrigue
J R
JR
D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004992:Ethics, Medical; D006291:Health Policy; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy* / Q000453:epidemiology; D006801:Humans; D007372:Interferons / Q000009:adverse effects / Q000627:therapeutic use*; D018447:Medical Futility; D010349:Patient Compliance; D017410:Practice Guidelines as Topic; D012306:Risk; D015819:Substance Abuse, Intravenous / Q000150:complications* / Q000523:psychology / Q000628:therapy; D019966:Substance-Related Disorders / Q000150:complications / Q000523:psychology / Q000628:therapy; D014481:United States / Q000453:epidemiology
D000998:Antiviral Agents; D007372:Interferons